Symptoms and Disease Progression of SPG89
At a Glance
SPG89 causes progressive leg stiffness and weakness that can affect walking, balance, and stamina. Some children may have developmental differences or bladder symptoms. Progression varies, and regular monitoring and physical therapy can support function and help prevent complications.
Understanding the progression of SPG89 (also known as AMFR-related hereditary spastic paraplegia) is a journey of monitoring and adaptation. Because the condition is so rare, your child’s experience may not follow a single, predictable path. Instead, the focus is on two main areas: how the muscles in the legs are functioning and whether other parts of development, such as learning or speech, are being affected [1].
Core Motor Symptoms
The most consistent feature of SPG89 is progressive lower-limb spasticity. This refers to a persistent stiffness in the leg muscles that makes movement more difficult over time [1]. In children, this often presents in specific ways:
- Gait Issues: You may notice your child walking on their toes (equinus gait), scissoring their legs (where the knees or thighs cross while walking), or dragging their feet [1][2].
- Motor Dysfunction: This includes difficulty with balance, frequent tripping, or a general clumsiness that seems to worsen as the child grows [1].
- Weakness: While stiffness is the most obvious sign, the underlying muscles in the legs and hips can also become weak, making it harder to climb stairs or keep up with peers during play [1].
Pure vs. Complex HSP
Doctors often use descriptive clinical terms to categorize hereditary spastic paraplegia. In the limited number of families identified with SPG89 so far, both presentations have been observed:
| Category | Description in SPG89 |
|---|---|
| Pure HSP Presentation | Symptoms are primarily limited to the legs [1]. While this label implies the absence of major systemic issues, a child’s cognition, speech, and overall development should still be individually assessed rather than assumed to be entirely typical. |
| Complex (Complicated) HSP Presentation | In addition to leg stiffness, there are “plus” symptoms. In SPG89 cohorts, this has included global developmental delay and mild intellectual disability [1][3]. |
It is important to remember that these categories are descriptive terms, not fixed prognostic stages. A child’s needs should be assessed individually.
Bladder and Autonomic Symptoms
While the specific frequency of bladder issues in SPG89 is not well established due to the small cohort size, many broader forms of HSP involve the autonomic nervous system, which controls involuntary functions. The most common of these is a neurogenic bladder [4]. This occurs because the same nerves that are struggling to send signals to the legs also control the bladder [5].
Signs to watch for include:
- Urgency: A sudden, strong need to urinate that is difficult to delay.
- Frequency: Needing to go to the bathroom much more often than usual.
- Incomplete Emptying: The feeling that the bladder isn’t fully empty after using the bathroom [4].
- Retention: Difficulty starting the flow of urine.
When to Seek Prompt Care: If you notice an inability to urinate, fever combined with urinary symptoms, blood in the urine, or severe flank/back pain, seek prompt medical assessment rather than watchful monitoring alone.
How the Condition Progresses
The word progressive can be scary for parents. In the context of SPG89, it means that symptoms like stiffness and weakness tend to increase over time [1][3].
In early childhood, the focus is often on reaching milestones like walking. As the child enters school age and adolescence, the spasticity may become more prominent as the bones grow faster than the tight muscles can stretch. This can sometimes lead to contractures, where the joints become “stuck” in a certain position because the muscles are too tight to let them move fully [6].
Every child is unique. In a small study of SPG89, there was variability in mobility outcomes [1]. Progression is not a straight line, and with regular physical therapy and medical monitoring, the goal is to support function and prevent complications [6]. Keeping a simple log of walking distance, falls, pain, fatigue, and bladder habits can help you and your care team track function objectively without treating every difficult day as a sign of disease progression.
Common questions in this guide
What are the main signs of SPG89 in children?
Does every child with SPG89 have developmental delay?
How does SPG89 change as a child grows?
What bladder problems should parents watch for with SPG89?
Can physical therapy slow SPG89 progression?
How are contractures monitored in a child with SPG89?
Get notified when new evidence is published on spastic paraplegia 89, autosomal recessive.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (6)
- 1
AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model.
Deng R, Medico-Salsench E, Nikoncuk A, et al.
Acta neuropathologica 2023; (146(2)):353-368 doi:10.1007/s00401-023-02579-9.
PMID: 37119330 - 2
Childhood-onset hereditary spastic paraplegia: at the crossroads between neurodevelopment and neurodegeneration.
Espasandin-Hueter N, Salazar-Villacorta A, Escudero JM, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (65()):50-65 doi:10.1016/j.ejpn.2026.10.002.
PMID: 42976539 - 3
Experience in the clinical and genetic diagnosis of a series of Algerian patients with hereditary spastic paraplegias.
Messaoud-Khelifi M, Boulariah-Hadjou R, Kediha MI, et al.
Neurogenetics 2025; (26(1)):52 doi:10.1007/s10048-025-00833-8.
PMID: 40560206 - 4
Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).
Rattay TW, Boldt A, Völker M, et al.
Journal of neurology 2020; (267(2)):369-379 doi:10.1007/s00415-019-09573-w.
PMID: 31646384 - 5
Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.
Mo A, Saffari A, Kellner M, et al.
Movement disorders : official journal of the Movement Disorder Society 2022; (37(12)):2440-2446 doi:10.1002/mds.29225.
PMID: 36103453 - 6
French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.
Mania-Pâris L, Ewenczyk C, Nicolas G, et al.
Revue neurologique 2025; (181(6)):471-482 doi:10.1016/j.neurol.2025.05.001.
PMID: 40450402
This page describes SPG89 symptoms and progression for informational purposes only and does not constitute medical advice. Your child’s neurologist and care team should interpret individual changes and recommend monitoring or treatment.